KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) Operating Expenses (2016 - 2026)

Quest Diagnostics' Operating Expenses history spans 18 years, with the latest figure at $2.5 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 8.24% to $2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $9.7 billion, a 10.3% increase, with the full-year FY2025 number at $9.5 billion, up 11.18% from a year prior.
  • Operating Expenses hit $2.5 billion in Q1 2026 for Quest Diagnostics, up from $2.4 billion in the prior quarter.
  • Over the last five years, Operating Expenses for DGX hit a ceiling of $2.5 billion in Q1 2026 and a floor of $2.0 billion in Q3 2023.
  • Historically, Operating Expenses has averaged $2.2 billion across 5 years, with a median of $2.1 billion in 2022.
  • Biggest five-year swings in Operating Expenses: fell 8.05% in 2023 and later increased 13.76% in 2025.
  • Tracing DGX's Operating Expenses over 5 years: stood at $2.2 billion in 2022, then decreased by 8.05% to $2.0 billion in 2023, then increased by 11.83% to $2.3 billion in 2024, then increased by 7.08% to $2.4 billion in 2025, then rose by 3.14% to $2.5 billion in 2026.
  • Business Quant data shows Operating Expenses for DGX at $2.5 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.